{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:43:20Z","timestamp":1790826200409,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114836","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:45:34Z","timestamp":1747068334000},"page":"114836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification of VDAC1 as a mitochondria-related target of Duchenne muscular dystrophy based on bioinformatics analysis and in vitro experiments"],"prefix":"10.1016","volume":"158","author":[{"given":"Wenjuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114836_bb0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.pcl.2015.03.008","article-title":"Genetics and emerging treatments for Duchenne and Becker muscular dystrophy","volume":"62","author":"Wein","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.intimp.2025.114836_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2025.114836_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","article-title":"Long-term outcome of interdisciplinary Management of Patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment","volume":"182","author":"Wong","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.intimp.2025.114836_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fgene.2018.00114","article-title":"Combined therapies for Duchenne muscular dystrophy to optimize treatment efficacy","volume":"9","author":"Cordova","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2025.114836_bb0025","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s12015-024-10756-w","article-title":"Chimeric cell therapy transfers healthy donor mitochondria in Duchenne muscular dystrophy","volume":"20","author":"Siemionow","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.intimp.2025.114836_bb0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fphys.2020.00690","article-title":"Mitochondrial dysfunction is an early consequence of partial or complete dystrophin loss in mdx mice","volume":"11","author":"Moore","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.114836_bb0035","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1113\/JP280316","article-title":"Mapping the role of mitochondrial DRP1 in skeletal muscle health: is too much and too little a bad thing?","volume":"598","author":"Gandhi","year":"2020","journal-title":"J. Physiol."},{"key":"10.1016\/j.intimp.2025.114836_bb0040","doi-asserted-by":"crossref","first-page":"9159101","DOI":"10.1155\/2022\/9159101","article-title":"Ginsenoside Rb1 prevents oxidative stress-induced apoptosis and mitochondrial dysfunction in muscle stem cells via NF-kappaB pathway","volume":"2022","author":"Dong","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2025.114836_bb0045","article-title":"Mitochondrial dysfunction as an underlying cause of skeletal muscle disorders","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114836_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115763","article-title":"Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency","volume":"9","author":"Rybalka","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.114836_bb0055","article-title":"The interplay of Mitophagy and inflammation in Duchenne muscular dystrophy","volume":"11","author":"Reid","year":"2021","journal-title":"Life (Basel)."},{"key":"10.1016\/j.intimp.2025.114836_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells13070574","article-title":"Mitochondria and reactive oxygen species: the therapeutic balance of powers for Duchenne muscular dystrophy","volume":"13","author":"Casati","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.114836_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2017.09.001","article-title":"Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy","volume":"125","author":"Schiavone","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.114836_bb0070","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1038\/s41598-020-66016-7","article-title":"miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy","volume":"10","author":"Sanson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114836_bb0075","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1038\/s41598-024-57340-3","article-title":"MCU-independent ca(2+) uptake mediates mitochondrial ca(2+) overload and necrotic cell death in a mouse model of Duchenne muscular dystrophy","volume":"14","author":"Bround","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114836_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165674","article-title":"Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition","volume":"1866","author":"Dubinin","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.intimp.2025.114836_bb0085","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm1736","article-title":"Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy","volume":"14","author":"Millay","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.114836_bb0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy--analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2025.114836_bb0095","doi-asserted-by":"crossref","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","article-title":"MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations","volume":"49","author":"Rath","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114836_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinfo."},{"key":"10.1016\/j.intimp.2025.114836_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114836_bb0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinfo."},{"key":"10.1016\/j.intimp.2025.114836_bb0115","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v046.i11","article-title":"Fast R functions for robust correlations and hierarchical clustering","volume":"46","author":"Langfelder","year":"2012","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.intimp.2025.114836_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/cdd.2016.127","article-title":"Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy","volume":"24","author":"Vila","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2025.114836_bb0125","first-page":"C718","article-title":"Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming?","volume":"323","author":"Bellissimo","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.intimp.2025.114836_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/hmg\/dds415","article-title":"Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition","volume":"22","author":"Percival","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2025.114836_bb0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3389\/fphys.2018.01087","article-title":"Drug repurposing for Duchenne muscular dystrophy: the monoamine oxidase B inhibitor safinamide ameliorates the pathological phenotype in mdx mice and in myogenic cultures from DMD patients","volume":"9","author":"Vitiello","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.114836_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2025.114836_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.891670","article-title":"Identification of auxiliary biomarkers and description of the immune microenvironmental characteristics in Duchenne muscular dystrophy by Bioinformatical analysis and experiment","volume":"16","author":"Han","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2025.114836_bb0150","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1016\/j.cell.2024.08.041","article-title":"Profound cellular defects attribute to muscular pathogenesis in the rhesus monkey model of Duchenne muscular dystrophy","volume":"187","author":"Ren","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.114836_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101366","article-title":"Inflammation in Duchenne muscular dystrophy-exploring the role of neutrophils in muscle damage and regeneration","volume":"9","author":"Tulangekar","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.114836_bb0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.omtm.2023.06.002","article-title":"Innate and adaptive AAV-mediated immune responses in a mouse model of Duchenne muscular dystrophy","volume":"30","author":"Emami","year":"2023","journal-title":"Mol Ther Methods Clin Dev."},{"key":"10.1016\/j.intimp.2025.114836_bb0165","doi-asserted-by":"crossref","first-page":"14592","DOI":"10.1016\/S0021-9258(18)42082-0","article-title":"Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation","volume":"267","author":"Stepien","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114836_bb0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2022.05.022","article-title":"The mitochondrial adenine nucleotide transporters in myogenesis","volume":"188","author":"Flierl","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2025.114836_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1568026620666201202102448","article-title":"GPRASP\/ARMCX protein family: potential involvement in health and diseases revealed by their novel interacting partners","volume":"21","author":"Kaeffer","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.intimp.2025.114836_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi2767","article-title":"Molkentin, ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy","volume":"9","author":"Bround","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2025.114836_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.25517","article-title":"COX6A2 variants cause a muscle-specific cytochrome c oxidase deficiency","volume":"86","author":"Inoue","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.114836_bb0190","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/s41598-024-53314-7","article-title":"NDUFS7 variant in dogs with Leigh syndrome and its functional validation in a Drosophila melanogaster model","volume":"14","author":"Christen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114836_bb0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mam.2010.03.002","article-title":"VDAC, a multi-functional mitochondrial protein regulating cell life and death","volume":"31","author":"Shoshan-Barmatz","year":"2010","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.intimp.2025.114836_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15698\/cst2017.10.104","article-title":"VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress","volume":"1","author":"Shoshan-Barmatz","year":"2017","journal-title":"Cell Stress"},{"key":"10.1016\/j.intimp.2025.114836_bb0205","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1074\/jbc.M006587200","article-title":"Altered mitochondrial sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-deficient mice","volume":"276","author":"Anflous","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114836_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179946","article-title":"Targeting the mitochondrial protein VDAC1 as a potential therapeutic strategy in ALS","volume":"23","author":"Shteinfer-Kuzmine","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114836_bb0215","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/ijbs.76223","article-title":"Molecular mechanisms of mitochondrial quality control in ischemic cardiomyopathy","volume":"19","author":"Chang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.114836_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fphys.2018.00215","article-title":"Mechanistic role of reactive oxygen species and therapeutic potential of antioxidants in denervation- or fasting-induced skeletal muscle atrophy","volume":"9","author":"Qiu","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.114836_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121948","article-title":"Targeting NAT10 protects against sepsis-induced skeletal muscle atrophy by inhibiting ROS\/NLRP3","volume":"330","author":"Wang","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114836_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40170-015-0133-5","article-title":"Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation","volume":"3","author":"Brahimi-Horn","year":"2015","journal-title":"Cancer Metab."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:37:11Z","timestamp":1751427431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925008264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"alternative-id":["S1567576925008264"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114836","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of VDAC1 as a mitochondria-related target of Duchenne muscular dystrophy based on bioinformatics analysis and in vitro experiments","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114836"}}